HIV News and Research

RSS

Cabotegravir highly effective in preventing HIV among women

UNAIDS has been strongly encouraged by groundbreaking new study results showing that the antiretroviral medicine cabotegravir administered by an injection every two months – prevents HIV among women.

10 Nov 2020

Promising new antivirals target arboviruses and SARS-CoV-2: Nodosome inhibitors

A new study describes two promising small molecules that inhibit a host cell factor, called nucleotide binding oligomerization domain-containing protein 2 (NOD2), that inhibits the replication and spread of many arboviruses. This could lead to the development of broad-spectrum antivirals. The study's findings have been published on the preprint server bioRxiv*.

10 Nov 2020

Trump’s anti-abortion zeal shook fragile health systems around the world

In Ethiopia, health clinics for teenagers once supported by U.S. foreign aid closed down. In Kenya, a decades-long effort to integrate HIV testing and family planning unraveled.

10 Nov 2020

UVA develops new method to understand how HIV begins the infection process

Scientists at the University of Virginia School of Medicine have developed a method to understand how HIV and other viruses first begin to infect our cells, and that could help us prevent COVID-19 and other diseases.

10 Nov 2020

Researchers shed new light on stigma and conspiracy theories about coronavirus

The World Health Organization calls the spread of false information about the coronavirus (COVID-19) an "infodemic," and the results are broadly visible across society.

10 Nov 2020

Trial results show CAB LA is more effective in preventing HIV acquisition in women

The HIV Prevention Trials Network study (HPTN 084) on the safety and efficacy of the long-acting injectable antiretroviral drug cabotegravir (CAB LA), for pre-exposure prophylaxis (PrEP) in HIV-uninfected women, was stopped early by the trial Data and Safety Monitoring Board (DSMB) as results showed CAB LA to be highly effective in preventing HIV acquisition.

10 Nov 2020

Lupus patients receiving prophylactic therapy are at high risk for adverse reactions

New research shows that adults with systemic lupus erythematosus, who receive trimethoprim-sulfamethoxazole (TMP-SMX), a prophylactic therapy to help prevent pneumocystis pneumonia, are at high risk for adverse reactions to the drug, particularly if they are also positive for anti-Smith (anti-Sm) antibodies.

6 Nov 2020

Study: Genetically edited form of herpes simplex virus outperforms leading vaccine candidate

A genetically edited form of a herpes simplex virus -- rewired to keep it from taking refuge in the nervous system and eluding an immune response -- has outperformed a leading vaccine candidate in a new study from the University of Cincinnati, Northwestern University and the University of Nebraska-Lincoln.

6 Nov 2020

WHO welcomes SHINE trial results on shorter treatment for drug-susceptible TB in children

The World Health Organization's Global TB Programme welcomes the results from an important study on shortened treatment for drug-susceptible tuberculosis in children, presented at the 51st virtual Union World Conference on Lung Health.

2 Nov 2020

SARS-CoV-2 virus may target red marrow and prevent the formation of new erythrocytes

Specialists from the Department of Fundamental Medicine of Far Eastern Federal University (FEFU) with Russian and Japanese colleagues have probed into mechanisms of COVID-19 inside-the-body distribution linked to erythrocytes damaging.

30 Oct 2020

Researchers seek to understand HIV-related attitudes of nursing faculty in six countries

Since the earliest study about nursing faculty and students attitudes and beliefs about caring for people living with HIV/AIDS (PLHIV) in the early 1990's, there have only been 17 additional studies. Knowledge in this area of study is still lacking to fill some gaps in understanding attitudes towards people living with the disease.

30 Oct 2020

Study identifies new cause of inflammation in people living with HIV

While current antiretroviral treatments for HIV are highly effective, data has shown that people living with HIV appear to experience accelerated aging and have shorter lifespans - by up to five to 10 years - compared to people without HIV.

30 Oct 2020

Study: Toxins produced by tube-dwelling anemones have pharmacological potential

Researchers based in Brazil and the United States have completed the first-ever mapping exercise to profile the toxins produced by tube-dwelling anemones, or cerianthids, a family of marine animals belonging to the same phylum (Cnidaria) as sea anemones, jellyfish and corals.

30 Oct 2020

MD65 IgG-YTE shows powerful post-exposure neutralization of SARS-CoV-2

A recent study published in the preprint server bioRxiv in October 2020 describes a reliable animal model to demonstrate the powerful capacity of human neutralizing mAbs directed against SARS-CoV-2 to prevent viral binding the host cell receptor and thus block infection. This indicates the lifesaving value of mAbs in severe COVID-19.

29 Oct 2020

UH and CWRU announce Phase 3 trial of Astrazeneca's investigational COVID-19 vaccine

University Hospitals and Case Western Reserve University announced today that UH Cleveland Medical Center has been selected as a clinical trial site for the Phase 3 global study of an investigational vaccine against SARS-CoV-2, sponsored by AstraZeneca.

29 Oct 2020

Antiviral inhibitor DDX42 shows broad activity against Chikungunya, HIV and SARS-CoV-2

By exploiting type 1 interferon's ability to foster an antagonistic cellular environment for viral replication, a research group from France pinpointed DEAD-box RNA helicase DDX42 as an intrinsic inhibitor of HIV, but also other pathogenic viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Chikungunya virus.

29 Oct 2020

Cost of Covid-19 tests plays key role in people’s willingness to undergo testing

Where and how long can schools remain open in times of the Corona pandemic? How safe are public transport means? Which rules must be observed when organizing events? To answer these questions, systematic tests for Corona infections and antibodies are of decisive importance.

28 Oct 2020

Rapid CD169 assay for COVID-19 screening

Researchers in France have conducted a study demonstrating the sensitivity of a rapid flow cytometry assay that could be used to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

27 Oct 2020

U.S. essential hospitals urge public to practice simple yet effective safety measures

Valleywise Health of Phoenix, America's Essential Hospitals, and a dozen essential hospitals - those with a safety-net mission - joined together in an urgent call for all Americans to remain vigilant and continue preventive actions to combat the spread of COVID-19.

27 Oct 2020

Study reveals human protein that helps the immune system fight viral infections

University of North Carolina School of Medicine scientists has made a curious discovery about a well-known human protein that helps the immune system fight viral infections.

27 Oct 2020

HIV News and Research

Cabotegravir highly effective in preventing HIV among women

Promising new antivirals target arboviruses and SARS-CoV-2: Nodosome inhibitors

Trump’s anti-abortion zeal shook fragile health systems around the world

UVA develops new method to understand how HIV begins the infection process

Researchers shed new light on stigma and conspiracy theories about coronavirus

Trial results show CAB LA is more effective in preventing HIV acquisition in women

Lupus patients receiving prophylactic therapy are at high risk for adverse reactions

Study: Genetically edited form of herpes simplex virus outperforms leading vaccine candidate

WHO welcomes SHINE trial results on shorter treatment for drug-susceptible TB in children

SARS-CoV-2 virus may target red marrow and prevent the formation of new erythrocytes

Researchers seek to understand HIV-related attitudes of nursing faculty in six countries

Study identifies new cause of inflammation in people living with HIV

Study: Toxins produced by tube-dwelling anemones have pharmacological potential

MD65 IgG-YTE shows powerful post-exposure neutralization of SARS-CoV-2

UH and CWRU announce Phase 3 trial of Astrazeneca's investigational COVID-19 vaccine

Antiviral inhibitor DDX42 shows broad activity against Chikungunya, HIV and SARS-CoV-2

Cost of Covid-19 tests plays key role in people’s willingness to undergo testing

Rapid CD169 assay for COVID-19 screening

U.S. essential hospitals urge public to practice simple yet effective safety measures

Study reveals human protein that helps the immune system fight viral infections

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News